October 19, 2026

Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC

Tempus: Study presented at ESMO evaluated more than 60,000 advanced NSCLC cases and found greater than 80% sensitivity across all 12 biomarkers using routine H&E pathology images CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today...

recent articles

  Deep learning is highly flexible and scalable, it can learn features by itself, making it an extremely powerful tool for image analysis. The Aiforia Platform enables easy access to deep learning and the creation of AI models for the...

Would you like a hands-on, personalized training experience and design image analysis APPs or perhaps take your APP designing skills to the next level? Then continue reading. Sign up for Visiopharm's image analysis courses for beginners...

WEBINAR – THURSDAY, OCTOBER 24TH 11 am CEST – SAVE YOUR SEAT 10 am PDT | 1 pm EDT – SAVE YOUR SEAT Join Visiopharm Thursday, 24th of October for a peek at the new image analysis algorithm that will simplify your workflow and...

U.S. Patent No. 10,346,980 addresses techniques critical to the advancement of digital pathology PHILADELPHIA (PRWEB) SEPTEMBER 24, 2019 -- Proscia, a leading provider of digital pathology software, has been granted U.S. Patent No. 10,346,980...

23 October, 2019  8:00 PDT | 11:00 EDT | 16:00 BST | 23:00 CST Presented by Anne Hellebust, PhD | Life Sciences Product Manager, Indica Labs, Inc. Vlado Ovtcharov | Senior Algorithm Engineer, Indica Labs,...

OR

platinum partners

gold partners

Silver Partners

Media Partners